These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19500909)

  • 1. Progressing towards acceptable treatment outcomes.
    Vowles KE; Robinson ME
    Pain; 2009 Aug; 144(3):228-229. PubMed ID: 19500909
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic low back pain analgesic studies--a methodological minefield.
    Moore AR; Straube S; Derry S; McQuay HJ
    Pain; 2010 Jun; 149(3):431-434. PubMed ID: 20304558
    [No Abstract]   [Full Text] [Related]  

  • 3. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain.
    Turk DC; Dworkin RH; Revicki D; Harding G; Burke LB; Cella D; Cleeland CS; Cowan P; Farrar JT; Hertz S; Max MB; Rappaport BA
    Pain; 2008 Jul; 137(2):276-285. PubMed ID: 17937976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Afterword: five steps to increase the payoff of chronic pain trials.
    Max MB
    Neurology; 2005 Dec; 65(12 Suppl 4):S74-7. PubMed ID: 16385108
    [No Abstract]   [Full Text] [Related]  

  • 5. Cut-points for the measurement of pain: the choice depends on what you want to study.
    Farrar JT
    Pain; 2010 May; 149(2):163-164. PubMed ID: 20347224
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward a definition of pharmacoresistant neuropathic pain.
    Hansson PT; Attal N; Baron R; Cruccu G
    Eur J Pain; 2009 May; 13(5):439-40. PubMed ID: 19324579
    [No Abstract]   [Full Text] [Related]  

  • 7. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Peirce-Sandner S; Baron R; Bellamy N; Burke LB; Chappell A; Chartier K; Cleeland CS; Costello A; Cowan P; Dimitrova R; Ellenberg S; Farrar JT; French JA; Gilron I; Hertz S; Jadad AR; Jay GW; Kalliomäki J; Katz NP; Kerns RD; Manning DC; McDermott MP; McGrath PJ; Narayana A; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Reeve BB; Rhodes T; Sampaio C; Simpson DM; Stauffer JW; Stucki G; Tobias J; White RE; Witter J
    Pain; 2010 May; 149(2):177-193. PubMed ID: 20207481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can we learn from failed neuropathic pain trials?
    Polydefkis M; Raja SN
    Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality improvement in neurology: Neurology Outcomes Quality Measurement Set.
    Sico JJ; Sarwal A; Benish SM; Busis NA; Cohen BH; Das RR; Finsilver S; Halperin JJ; Kelly AG; Meunier L; Phipps MS; Thirumala PD; Villanueva R; von Gaudecker J; Bennett A; Shenoy AM
    Neurology; 2020 Jun; 94(22):982-990. PubMed ID: 32398356
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION.
    Dworkin RH; Turk DC; Katz NP; Rowbotham MC; Peirce-Sandner S; Cerny I; Clingman CS; Eloff BC; Farrar JT; Kamp C; McDermott MP; Rappaport BA; Sanhai WR
    Pain; 2011 Mar; 152(3 Suppl):S107-S115. PubMed ID: 21145657
    [No Abstract]   [Full Text] [Related]  

  • 11. Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain.
    McQuay HJ; Derry S; Moore AR; Poulain P; Legout V
    Pain; 2008 Apr; 135(3):217-220. PubMed ID: 18258369
    [No Abstract]   [Full Text] [Related]  

  • 12. A response to Wasan editorial "Spinal cord stimulation in a workers' compensation population: how difficult it can be to interpret a clinical trial": stimulating discussion.
    Turner JA; Hollingworth W; Comstock BA; Deyo RA
    Pain; 2010 May; 149(2):406-407. PubMed ID: 20207083
    [No Abstract]   [Full Text] [Related]  

  • 13. The significance of clinical significance.
    Turner JA; Turk DC
    Pain; 2008 Jul; 137(3):467-468. PubMed ID: 18455313
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.
    Moore RA; Derry S; McQuay HJ; Straube S; Aldington D; Wiffen P; Bell RF; Kalso E; Rowbotham MC;
    Pain; 2010 May; 149(2):173-176. PubMed ID: 19748185
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodological issues in clinical trials of opioids for chronic pain.
    Katz N
    Neurology; 2005 Dec; 65(12 Suppl 4):S32-49. PubMed ID: 16385103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for neuropathic pain.
    Jackson KC
    Pain Pract; 2006 Mar; 6(1):27-33. PubMed ID: 17309706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to Drs. Olanow and Rascol.
    Ahlskog JE; Uitti RJ
    Neurology; 2010 Apr; 74(14):1151. PubMed ID: 20368636
    [No Abstract]   [Full Text] [Related]  

  • 19. What do you expect from this treatment? Changing our mind about clinical trials.
    Benedetti F
    Pain; 2007 Apr; 128(3):193-194. PubMed ID: 17292547
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining the pharmacologically intractable headache for clinical trials and clinical practice.
    Silberstein SD; Dodick DW; Pearlman S
    Headache; 2010 Oct; 50(9):1499-506. PubMed ID: 20958296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.